Literature DB >> 7104211

Thalidomide treatment of subacute cutaneous lupus erythematosus.

B Naafs, E J Bakkers, J Flinterman, W R Faber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7104211     DOI： 10.1111/j.1365-2133.1982.tb00294.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  4 in total

1.  Diagnosis and management of systemic lupus erythematosus. Thalidomide modifies disease.

Authors:  N P Burrows
Journal:  BMJ       Date:  1993-10-09

Review 2.  Thalidomide in human immunodeficiency virus (HIV) patients. A review of safety considerations.

Authors:  V Günzler
Journal:  Drug Saf       Date:  1992 Mar-Apr       Impact factor: 5.606

3.  Treatment of Behçet's disease with thalidomide.

Authors:  M H Hamza
Journal:  Clin Rheumatol       Date:  1986-09       Impact factor: 2.980

4.  Effects of oral thalidomide on rat liver and skin microsomal P450 isozyme activities and on urinary porphyrin excretion: interaction with oral hexachlorobenzene.

Authors:  D Tsambaos; K Bolsen; S Georgiou; A Monastirli; G Goerz
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.